Nadia A. Khalil

777 total citations
41 papers, 641 citations indexed

About

Nadia A. Khalil is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Nadia A. Khalil has authored 41 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 10 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Nadia A. Khalil's work include Synthesis and biological activity (25 papers), Synthesis and Biological Evaluation (11 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Nadia A. Khalil is often cited by papers focused on Synthesis and biological activity (25 papers), Synthesis and Biological Evaluation (11 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Nadia A. Khalil collaborates with scholars based in Egypt, Ireland and United Kingdom. Nadia A. Khalil's co-authors include Eman Ahmed, Azza T. Taher, Khaled A. M. Abouzid, Hala B. El‐Nassan, Sawsan A. Zaitone, Khaled O. Mohamed, Yassin M. Nissan, Maher I. Nessim, Ahmed M. Al‐Abd and Alaa Ghanem and has published in prestigious journals such as Scientific Reports, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Nadia A. Khalil

41 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nadia A. Khalil Egypt 16 489 148 83 50 47 41 641
Hanan A. Soliman Egypt 17 643 1.3× 120 0.8× 119 1.4× 15 0.3× 19 0.4× 38 748
Hanan Al-Ghulikah Saudi Arabia 15 379 0.8× 163 1.1× 68 0.8× 45 0.9× 54 1.1× 39 563
Mohamed M. Hammouda Egypt 12 353 0.7× 97 0.7× 26 0.3× 22 0.4× 34 0.7× 42 442
Samir M. Awad Egypt 13 424 0.9× 118 0.8× 43 0.5× 23 0.5× 39 0.8× 35 542
Dengyou Zhang China 17 600 1.2× 171 1.2× 18 0.2× 37 0.7× 31 0.7× 27 788
Yasuyoshi Arikawa Japan 12 448 0.9× 204 1.4× 34 0.4× 17 0.3× 34 0.7× 23 843
Peter A. Sidhom Egypt 14 172 0.4× 129 0.9× 35 0.4× 8 0.2× 61 1.3× 54 460
Stéphanie Hesse France 14 424 0.9× 127 0.9× 32 0.4× 35 0.7× 33 0.7× 39 536
Tarek F. El‐Moselhy Egypt 14 226 0.5× 142 1.0× 30 0.4× 17 0.3× 35 0.7× 30 409
David S. Casebier United States 16 399 0.8× 230 1.6× 50 0.6× 18 0.4× 27 0.6× 22 1.2k

Countries citing papers authored by Nadia A. Khalil

Since Specialization
Citations

This map shows the geographic impact of Nadia A. Khalil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadia A. Khalil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadia A. Khalil more than expected).

Fields of papers citing papers by Nadia A. Khalil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nadia A. Khalil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadia A. Khalil. The network helps show where Nadia A. Khalil may publish in the future.

Co-authorship network of co-authors of Nadia A. Khalil

This figure shows the co-authorship network connecting the top 25 collaborators of Nadia A. Khalil. A scholar is included among the top collaborators of Nadia A. Khalil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadia A. Khalil. Nadia A. Khalil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khalil, Nadia A., et al.. (2025). Design, Synthesis, Docking Studies, and Investigation of Dual EGFR/VEGFR‐2 Inhibitory Potentials of New Pyrazole and Pyrazolopyridine Derivatives. Drug Development Research. 86(1). e70056–e70056. 3 indexed citations
2.
Khalil, Nadia A., et al.. (2024). Evaluation of ionic liquids based imidazolium salts as an environmentally friendly corrosion inhibitors for carbon steel in HCl solutions. Scientific Reports. 14(1). 1889–1889. 25 indexed citations
3.
Khalil, Nadia A., et al.. (2024). Pyridazine and pyridazinone derivatives: Synthesis and in vitro investigation of their anti‐inflammatory potential in LPS‐induced RAW264.7 macrophages. Drug Development Research. 85(2). e22173–e22173. 5 indexed citations
4.
Khalil, Nadia A., et al.. (2024). NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead. RSC Advances. 14(42). 30647–30661. 12 indexed citations
5.
6.
7.
Ghanem, Alaa, et al.. (2023). Imidazolium-based ionic liquids as dispersants to improve the stability of asphaltene in Egyptian heavy crude oil. Scientific Reports. 13(1). 17158–17158. 18 indexed citations
8.
9.
Khalil, Nadia A., et al.. (2021). New benzothieno[2,3-c]pyridines as non-steroidal CYP17 inhibitors: design, synthesis, anticancer screening, apoptosis induction, and in silico ADME profile studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1839–1859. 2 indexed citations
10.
Khalil, Nadia A., et al.. (2020). Efficient synthesis of new 3-amino-4-cyanothiophene derivatives. Chemical Papers. 74(8). 2491–2500. 2 indexed citations
11.
Ahmed, Eman, et al.. (2019). Triazolopyridazine derivatives: Synthesis, cytotoxic evaluation, c-Met kinase activity and molecular docking. Bioorganic Chemistry. 92. 103272–103272. 7 indexed citations
12.
Khalil, Nadia A., et al.. (2019). Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors. European Journal of Medicinal Chemistry. 187. 111926–111926. 16 indexed citations
13.
Khalil, Nadia A., Eman Ahmed, Khaled O. Mohamed, Yassin M. Nissan, & Sawsan A. Zaitone. (2014). Synthesis and biological evaluation of new pyrazolone–pyridazine conjugates as anti-inflammatory and analgesic agents. Bioorganic & Medicinal Chemistry. 22(7). 2080–2089. 52 indexed citations
14.
Abouzid, Khaled A. M., Nadia A. Khalil, Eman Ahmed, & Khaled O. Mohamed. (2013). 3-[(6-Arylamino)pyridazinylamino]benzoic acids: design, synthesis and in vitro evaluation of anticancer activity. Archives of Pharmacal Research. 36(1). 41–50. 17 indexed citations
15.
Khalil, Nadia A., et al.. (2013). Novel 4-substituted-2(1H)-phthalazinone derivatives: synthesis, molecular modeling study and their effects on α-receptors. Archives of Pharmacal Research. 36(6). 671–683. 3 indexed citations
16.
Khalil, Nadia A., et al.. (2012). Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone derivatives as non-ulcerogenic agents. Archives of Pharmacal Research. 35(12). 2077–2092. 42 indexed citations
17.
Khalil, Nadia A., et al.. (2012). Synthesis and anticonvulsant activity of new phenytoin derivatives. European Journal of Medicinal Chemistry. 60. 57–63. 55 indexed citations
18.
Khalil, Nadia A., et al.. (2012). Synthesis and biological evaluation of novel pyrazoline derivatives as anti-inflammatory and antioxidant agents. Archives of Pharmacal Research. 35(6). 995–1002. 28 indexed citations
19.
Khalil, Nadia A., et al.. (2012). Phenytoin-based bivalent ligands: Design, synthesis and anticonvulsant activity. Archives of Pharmacal Research. 35(12). 2105–2116. 3 indexed citations
20.
Abouzid, Khaled A. M., Nadia A. Khalil, Eman Ahmed, Ahmed Esmat, & Ahmed M. Al‐Abd. (2011). Design, synthesis, and evaluation of anti-inflammatory and ulcerogenicity of novel pyridazinone derivatives. Medicinal Chemistry Research. 21(11). 3581–3590. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanan A. Soliman Breakdown of academic impact, for papers by Hanan Al-Ghulikah Breakdown of academic impact, for papers by Mohamed M. Hammouda Breakdown of academic impact, for papers by Samir M. Awad Breakdown of academic impact, for papers by Dengyou Zhang Breakdown of academic impact, for papers by Yasuyoshi Arikawa Breakdown of academic impact, for papers by Peter A. Sidhom Breakdown of academic impact, for papers by Stéphanie Hesse Breakdown of academic impact, for papers by Tarek F. El‐Moselhy Breakdown of academic impact, for papers by David S. Casebier
Rankless by CCL
2026